Market Access Opportunities & Challenges: An Exploration of Three Global Trends

Home / Intelligence / Webinars / Market Access Opportunities & Challenges: An Exploration of Three Global Trends

Available On Demand

Join Trinity Life Sciences’ Evidence, Value, Access and Pricing and Cell & Gene Therapy experts for a deeper look at the market access trends that will present the most impactful opportunities and challenges for life sciences organizations in 2023.

This webinar will expand upon the trends discussed in the recently released white paper entitled “Global Market Access Trends: 2022 Edition,” focusing on evolving evidence expectations, increasing price transparency regulation and cell & gene therapy expansion.

Key Webinar Topics

  • How can life sciences organizations meet evolving evidence expectations in the U.S. and Europe?
  • How can the price of pharmaceutical products be successfully negotiated as more stringent price transparency regulation is enforced globally?
  • How can organizations keep pace with the evolving cell and gene therapy pricing and reimbursement landscape as this new technology expands?


Complete the form below to view the on-demand webinar.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email

This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.

Related Intelligence


2023 NRDL Update: An Ongoing Voyage of Innovation and Accessibility

May 1, 2024 | 12:00 – 12:45 PM ET / 18:00 – 18:45 CET

An additional session will be offered on May 7th at 16:00-16:45 (UTC+8:00) – Asia/Shanghai How can manufacturers strategize for pricing and market access success amidst the evolving landscape of China’s NRDL? As China continues to be a key pharmaceutical market, understanding the latest National Reimbursement Drug List (NRDL) trends and policy evolvement is crucial for […]

 Sign Up Now


Rise with the waves: Canada – A Coming (R)evolution: Transforming Pharmaceutical Market Access

Executive Summary Canada has undertaken meaningful strategies to transform patient access and ultimately improve health outcomes across the country. Two such potentially high-impact strategies include the planned transformation of the former Canadian Agency for Drugs and Technology in Health (CADTH) into the new Canadian Drug Agency (CDA) over the course of the next five years, […]

 Read More


Using Transparency in Coverage Reimbursement Insights to Inform Payer and Provider Contracting Strategy

Executive Summary “Transparency in Coverage” (TIC) data is a newer data source that has recently become available for mining unique insights in the reimbursement/economics between payers and providers. In 2020, the Federal Government TIC Rule required health insurers and group health plans, including self-funded clients, to provide cost-sharing data to consumers via machine-readable files and […]

 Read More